September Is Sickle Cell Awareness Month. While many people are familiar with sickle cell anemia, sickle cell traits have also plagued our community. Sickle cell trait (SCT) is an inherited blood ...

Contrary to misconceptions among medical professionals and patients alike, individuals born with sickle cell trait (SCT) show no risk of experiencing the acute pain crises known to occur with sickle ...

After the untimely death of his teen son, the father of the late Justin Johnson went to Central Dauphin East High for an ...

Sickle cell disease is a global public health issue. Individuals with sickle cell disease (SCD) have two genes that cause the production of sickle hemoglobin, and these patients can have severe pain ...

One of the most vital treatments for sickle cell patients is regular blood transfusions; sometimes, it's needed multiple ...

Please provide your email address to receive an email when new articles are posted on . Sickle cell trait has no association with mortality from physical exertion or heat-related injuries without ...

“I told God, ‘I don’t think it’s time yet. I don’t feel like I did enough for you,’” she recalled. A pastor’s wife later ...

Sickle cell anemia can cause your blood cells to stick as they move through your body, leading to symptoms such as fatigue, intense pain, and jaundice. Symptoms such as chest pain may signal a sickle ...

People with sickle cell anemia, especially children, are more likely to experience a stroke. Silent strokes, which don’t cause noticeable symptoms, are especially common. Sickle cell anemia (SCA) is a ...

(Reuters Health) – African Americans with sickle cell trait - generally thought to be benign, unlike sickle cell disease - may still be at increased risk of kidney disease, a new study suggests. Based ...

The only cure for painful sickle cell disease today is a bone marrow transplant. But soon there may be a new cure that attacks the disorder at its genetic source. On Tuesday, advisers to the Food and ...

Jayden Wilsey was the first person at Boston Children's Hospital to receive human gene therapy for sickle cell disease after federal approval in 2024.